GlassScriptPhysician profile
Leslee Ann Lewis
NPI 1831664846
$8,352.67
in general payments reported to CMS, 2019-2025
18 companies · $2,608 in 2025
The $2,608 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,191 · 2022: $688 · 2023: $2,620 · 2024: $1,246 · 2025: $2,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,130 · Travel and Lodging: $2,212 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,130.39 |
| Travel and Lodging | $2,212.49 |
| Education | $131.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,225.59 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $1,923.86 | 2021-2025 | Navitor |
| Boston Scientific Corporation | $779.63 | 2021-2025 | Farapulse, Watchman Flx, General - Vascular Access |
| Medtronic, INC. | $315.88 | 2023-2025 | Corevalve Evolut R |
| Abiomed | $195.71 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $190.01 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $160.49 | 2021-2024 | Gore Cardioform Septal Occluder |
| Janssen Pharmaceuticals, INC | $145.84 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $91.35 | 2021-2025 | Lifevest |
| Amgen INC. | $86.57 | 2021-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $83.72 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $36.67 | 2021-2022 | |
| Stryker Corporation | $27.24 | 2025 | Flowtriever |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.82 | 2022 | |
| Cvrx, INC. | $19.37 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $18.38 | 2021 | |
| Pfizer INC. | $17.03 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslee Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.